Changing epidemiology of non-albicans candidemia in Korea

被引：24

作者：

Ko, Jae-Hoon ^{[1
,9
]}

Jung, Dong Sik ^{[2
]}

Lee, Ji Yeon ^{[3
]}

Kim, Hyun Ah ^{[3
]}

Ryu, Seong Yeol ^{[3
]}

Jung, Sook-In ^{[4
]}

Joo, Eun-Jeong ^{[5
]}

Cheon, Shinhye ^{[6
]}

Kim, Yeon-Sook ^{[6
]}

Kim, Shin-Woo ^{[7
]}

Cho, Sun Young ^{[1
]}

Kang, Cheol-In ^{[1
]}

Chung, Doo Ryeon ^{[1
]}

Lee, Nam Yong ^{[8
]}

Peck, Kyong Ran ^{[1
]}

机构：

[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Infect Dis,Dept Med, 81 Irwon Ro, Seoul 06531, South Korea

[2] Dong A Univ, Coll Med, Div Infect Dis, Busan, South Korea

[3] Keimyung Univ, Dongsan Med Ctr, Div Infect Dis, Daegu, South Korea

[4] Chonnam Natl Univ Hosp, Div Infect Dis, Gwangju, South Korea

[5] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Sch Med, Div Infect Dis,Dept Internal Med, Seoul, South Korea

[6] Chungnam Natl Univ, Sch Med, Div Infect Dis, Daejeon, South Korea

[7] Kyungpook Natl Univ, Sch Med, Div Infect Dis, Daegu, South Korea

[8] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Lab Med, Seoul, South Korea

[9] Armed Forces Capital Hosp, Dept Internal Med, Div Infect Dis, Seongnam, South Korea

来源：

JOURNAL OF INFECTION AND CHEMOTHERAPY | 2019年 / 25卷 / 05期

关键词：

Epidemiology; non-albicans Candida; Antifungal resistance; Candida glabrata; Candida parapsilosis; ANTIFUNGAL SUSCEPTIBILITY; SPECIES DISTRIBUTION; AMPHOTERICIN-B; HOSPITALS; VORICONAZOLE; FLUCONAZOLE; GLABRATA;

D O I：

10.1016/j.jiac.2018.09.016

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

An epidemiologic surveillance of non-albicans candidemia for a 6-year period was conducted in Korea. Compared to the published epidemiologic data for the previous 6 years, an increase of C. glabrata (from 21.3% to 28.5%) and a decrease of C. parapsilosis (from 36.5% to 24.7%) were noticed. During the study period, C. tropicalis (36.4%) was most frequently isolated non-albicans Candida, followed by C. glabrata (28.5%), C. parapsilosis (24.7%), and C. krusei (2.6%). Replacement of primary amphotericin B treatment with echinocandins (P < 0.001) eliminated amphotericin B resistance (from 7.8% in 2011 to 0% in 2014). (c) 2018 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

引用

页码：388 / 391

页数：4

共 50 条

[1] Non-albicans Candida in neonatal candidemia
Kumar, C. S. Vinod
Neelagund, Y. F.
INDIAN PEDIATRICS, 2006, 43 (09) : 825 - 825
[2] Multicenter surveillance of non-albicans candidemia
Hamill, RJ
Pappas, PG
Rex, JH
Lee, JY
Horowitz, H
Kauffman, CA
Hyslop, N
Larsen, RA
Stein, DK
Graviss, EA
Thomas, CJ
CLINICAL INFECTIOUS DISEASES, 2000, 31 (01) : 219 - 219
[3] Epidemiology, risk factors, and outcomes of Candida albicans versus non-albicans candidemia in nonneutropenic patients
Vandijck, Dominique M.
Blot, S.
Decruyenaere, J.
ANNALS OF PHARMACOTHERAPY, 2007, 41 (11) : 1916 - 1917
[4] Epidemiology, risk factors, and outcomes of Candida albicans versus non-albicans candidemia in nonneutropenic patients
Davis, Susan L.
Vazquez, Jose A.
McKinnon, Peggy S.
ANNALS OF PHARMACOTHERAPY, 2007, 41 (04) : 568 - 573
[5] Epidemiology, risk factors, and outcomes of candida albicans versus non-albicans candidemia in nonneutropenic patients - Reply
Davis, Susan L.
McKinnon, Peggy S.
ANNALS OF PHARMACOTHERAPY, 2007, 41 (11) : 1917 - 1917
[6] Risk factors for Candida non-albicans candidemia
Blot, Stijn
Vandijck, Dominique
Vandewoude, Koenraad
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2008, 61 (03) : 362 - 363
[7] Epidemiology and antifungal susceptibility of candidemia isolates of non-albicans Candida species from cancer patients
Wu, Ping-Feng
Liu, Wei-Lun
Hsieh, Min-Han
Hii, Ing-Moi
Lee, Yu-Lin
Lin, Yi-Tsung
Ho, Mao-Wang
Liu, Chun-Eng
Chen, Yen-Hsu
Wang, Fu-Der
EMERGING MICROBES & INFECTIONS, 2017, 6
[8] Risk factors for albicans and non-albicans candidemia in the intensive care unit
Chow, Jennifer K.
Golan, Yoav
Ruthazer, Robin
Karchmer, Adolf W.
Carmeli, Yehuda
Lichtenberg, Deborah A.
Chawla, Varun
Young, Janet A.
Hadley, Susan
CRITICAL CARE MEDICINE, 2008, 36 (07) : 1993 - 1998
[9] Risk factors for Candida non-albicans candidemia -: Response
Klevay, Michael J.
Diekema, Daniel J.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2008, 61 (03) : 364 - 364
[10] Poor prognosis of Candida tropicalis among non-albicans candidemia: a retrospective multicenter cohort study, Korea
Ko, Jae-Hoon
Jung, Dong Sik
Lee, Ji Yeon
Kim, Hyun Ah
Ryu, Seong Yeol
Jung, Sook-In
Joo, Eun-Jeong
Cheon, Shinhye
Kim, Yeon-Sook
Kim, Shin-Woo
Cho, Sun Young
Kang, Cheol-In
Chung, Doo Ryeon
Lee, Nam Yong
Peck, Kyong Ran
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2019, 95 (02) : 195 - 200

← 1 2 3 4 5 →